COVID-19-Induced Hair Shedding and Related Risk Factors: A Saudi Perspective

    December 2023 in “ Journal of family medicine and primary care ”
    Abrar E. Bukhari, Dalal abdullah AlDosari, Mubarak Aldosari … Abdullah Alkhalifah
    Studysummary This study in Saudi Arabia found that 59.70% of participants experienced hair shedding during or after COVID-19, with significant risk factors including being female, having a history of telogen effluvium, and receiving COVID-19 antiviral treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 17

    1. Telogen Effluvium After COVID-19 Vaccination Among Public in Saudi Arabia Journal of family medicine and primary care · 2022
    2. Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies International Journal of Molecular Sciences · 2022
    3. Covid Induced Telogen Effluvium: An Insight Indian Dermatology Online Journal · 2022
    4. The Role of SARS-CoV-2 Infection and Its Vaccines in Various Types of Hair Loss Dermatologic Therapy · 2022
    5. A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation Journal of Medical Virology · 2021
    6. Characteristics of Telogen Effluvium in COVID-19 in Western Iran (2020) Anais Brasileiros De Dermatologia · 2021
    7. COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium Irish Journal of Medical Science (1971 -) · 2021
    8. More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis Scientific Reports · 2021
    9. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021
    10. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    11. Cutaneous Manifestations and Considerations in COVID-19 Pandemic: A Systematic Review Dermatologic therapy · 2020
    12. Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire Dermatologic Therapy · 2020
    13. Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications Dermatologic Therapy · 2020
    14. Telogen Effluvium: A Comprehensive Review Clinical, Cosmetic and Investigational Dermatology · 2019
    15. Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature Drugs - Real World Outcomes · 2016
    16. Telogen Effluvium: A Comprehensive Review Archives of Dermatology · 1993
    17. Interferon Alfa-2a in the Treatment of Cutaneous T Cell Lymphoma Journal of The American Academy of Dermatology · 1989